comparemela.com

Johannesc Melms News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Study offers new insights into brain metastases in patients with melanoma

Brain metastasis is one of the most common causes of cancer-related deaths and occurs very frequently in patients with advanced melanoma.

Study: New insights into melanoma brain metastases

Cancer researchers have completed one of the most comprehensive studies of the cells inside melanoma brain metastases.

New Insights into Melanoma Brain Metastases

New Insights into Melanoma Brain Metastases
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

New cell atlas of COVID lungs reveals why SARS-CoV-2 is deadly and different

 E-Mail NEW YORK, NY (April 29, 2021) A new study is drawing the most detailed picture yet of SARS-CoV-2 infection in the lung, revealing mechanisms that result in lethal COVID-19, and may explain long-term complications and show how COVID-19 differs from other infectious diseases. Led by researchers at Columbia University Vagelos College of Physicians and Surgeons and Herbert Irving Comprehensive Cancer Center, the study found that in patients who died of the infection, COVID-19 unleashed a detrimental trifecta of runaway inflammation, direct destruction and impaired regeneration of lung cells involved in gas exchange, and accelerated lung scarring. Though the study looked at lungs from patients who had died of the disease, it provides solid leads as to why survivors of severe COVID may experience long-term respiratory complications due to lung scarring.

Melanoma Resistance to Checkpoint Therapy Scrutinized with Perturb-CITE-Seq

Melanoma Resistance to Checkpoint Therapy Scrutinized with Perturb-CITE-Seq March 1, 2021 Immune checkpoint inhibitors (ICIs), drugs that release the immune system’s “brakes,” are meant to expose cancer to the full force of the immune system’s attack. But in most cancer patients, ICIs leave the brakes engaged. To understand why this is the case and to identify ways that ICIs could succeed more often scientists based at Columbia University and the Massachusetts Institute of Technology have created a new technique to study ICI resistance (ICR). Essentially, the technique, which is called Perturb-CITE-sequencing (or Perturb-CITE-seq), surveys the pathways that cancer cells may use to escape ICI immunotherapy. Perturb-CITE-seq is an extension of Perturb-seq, a technique that combines CRISPR-based perturbation screens and massively parallel single-cell RNA sequencing. Like Perturb-seq, Perturb-CITE-seq provides RNA readouts. In addition, however, Perturb-CITE-seq provides prote

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.